Publication: Do comorbidities impact persistence of first tumor necrosis factor inhibitor treatment in rheumatoid arthritis? Data from Turkbio
dc.contributor.author | İnel, T. Yüce | |
dc.contributor.author | Kocaer, S. B. | |
dc.contributor.author | Erez, Y. | |
dc.contributor.author | Gülle, S. | |
dc.contributor.author | Karakaş, A. | |
dc.contributor.author | Avşar, A. Köken | |
dc.contributor.author | Uslu, S. | |
dc.contributor.author | Can, G. | |
dc.contributor.author | Sarı, I. | |
dc.contributor.author | Birlik, M. | |
dc.contributor.author | Dalkılıç, E. | |
dc.contributor.author | Pehlivan, Y. | |
dc.contributor.author | Akar, S. | |
dc.contributor.author | Göker, B. | |
dc.contributor.author | Çetin, G. Yıldırım | |
dc.contributor.author | Haznedaroğlu, S. | |
dc.contributor.author | Yavuz, S. | |
dc.contributor.author | Pırıldar, T. | |
dc.contributor.author | Direskeneli, H. | |
dc.contributor.author | Akkoç, N. | |
dc.contributor.author | Önen, F. | |
dc.contributor.author | Turkbio Registry Group | |
dc.contributor.buuauthor | DALKILIÇ, HÜSEYİN EDİZ | |
dc.contributor.buuauthor | PEHLİVAN, YAVUZ | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi. | |
dc.contributor.researcherid | AAG-8227-2021 | |
dc.contributor.researcherid | JHC-5173-2023 | |
dc.date.accessioned | 2024-07-04T08:27:10Z | |
dc.date.available | 2024-07-04T08:27:10Z | |
dc.date.issued | 2020-06-01 | |
dc.identifier.doi | 10.1136/annrheumdis-2020-eular.1599 | |
dc.identifier.endpage | 978 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issue | Supplement 1 | |
dc.identifier.startpage | 978 | |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2020-eular.1599 | |
dc.identifier.uri | https://ard.bmj.com/content/79/Suppl_1/982.1 | |
dc.identifier.uri | https://hdl.handle.net/11452/42883 | |
dc.identifier.volume | 79 | |
dc.identifier.wos | 000555905003171 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | BMJ Publishing Group | |
dc.relation.journal | Annals of the Rheumatic Diseases | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Rheumatology | |
dc.title | Do comorbidities impact persistence of first tumor necrosis factor inhibitor treatment in rheumatoid arthritis? Data from Turkbio | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 1613225c-2f43-4052-9f82-210c854edcf4 | |
relation.isAuthorOfPublication | 0075f2ae-ae8a-4690-bd46-128775e8efac | |
relation.isAuthorOfPublication.latestForDiscovery | 1613225c-2f43-4052-9f82-210c854edcf4 |